CTLT Catalent Inc

Catalent Inc is a drug development, delivery and supply partner company. It engages in advanced delivery technologies and development solutions for drugs, biologics, and consumer health products across US, Europe and other international markets.

$104.19  -0.36 (-0.34%)
As of 03/08/2021 10:04:07 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Large cap
Health Care
Drug Manufacturers—Specialty &
USA
USA
07/31/2014
170,226,514
1,000,425
$17,797,182,039
0.00%
SEC Edgar Online
10-Q
10-K
148806102
US1488061029
BP96PQ4

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
61.05
5.15
5.14
10.01%
9.98%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy